VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 144 filers reported holding VENTYX BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,814,250 | -4.7% | 225,000 | -10.0% | 1.04% | -6.5% |
| Q2 2023 | $8,200,000 | -9.3% | 250,000 | -7.4% | 1.12% | -13.9% |
| Q1 2023 | $9,045,000 | -58.0% | 270,000 | -58.9% | 1.30% | -48.7% |
| Q4 2022 | $21,543,555 | -55.8% | 657,016 | -53.0% | 2.52% | -57.9% |
| Q3 2022 | $48,793,000 | +72.5% | 1,397,680 | -39.6% | 6.00% | +15.6% |
| Q2 2022 | $28,284,000 | -17.1% | 2,312,680 | -8.0% | 5.19% | +17.3% |
| Q1 2022 | $34,119,000 | -5.8% | 2,514,280 | +37.8% | 4.42% | +18.4% |
| Q4 2021 | $36,230,000 | – | 1,824,280 | – | 3.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |